BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20503979)

  • 21. Further brominated polyacetylenes with pancreatic lipase inhibitory activity from Chinese marine sponge Xestospongia testudinaria.
    Yang M; Liang LF; Wang T; Wang HY; Liu HL; Guo YW
    J Asian Nat Prod Res; 2017 Jul; 19(7):732-737. PubMed ID: 28152617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors.
    Volgraf M; Chan L; Huestis MP; Purkey HE; Burkard M; Geck Do M; Harris J; Hunt KW; Liu X; Lyssikatos JP; Rana S; Thomas AA; Vigers GP; Siu M
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2477-80. PubMed ID: 24780121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors.
    Peschiulli A; Oehlrich D; Rombouts F; Vos A; Gijsen HJ
    Bioorg Med Chem Lett; 2020 Apr; 30(8):126999. PubMed ID: 32089426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.
    Azimi S; Zonouzi A; Firuzi O; Iraji A; Saeedi M; Mahdavi M; Edraki N
    Eur J Med Chem; 2017 Sep; 138():729-737. PubMed ID: 28728105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspartic proteases in drug discovery.
    Eder J; Hommel U; Cumin F; Martoglio B; Gerhartz B
    Curr Pharm Des; 2007; 13(3):271-85. PubMed ID: 17313361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 28. Green tea catechins as a BACE1 (beta-secretase) inhibitor.
    Jeon SY; Bae K; Seong YH; Song KS
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3905-8. PubMed ID: 14592472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BACE1 inhibitors: a head group scan on a series of amides.
    Woltering TJ; Wostl W; Hilpert H; Rogers-Evans M; Pinard E; Mayweg A; Göbel M; Banner DW; Benz J; Travagli M; Pollastrini M; Marconi G; Gabellieri E; Guba W; Mauser H; Andreini M; Jacobsen H; Power E; Narquizian R
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4239-43. PubMed ID: 23735744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand.
    Ghosh AK; Ghosh K; Brindisi M; Lendy EK; Yen YC; Kumaragurubaran N; Huang X; Tang J; Mesecar AD
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2605-2610. PubMed ID: 29970308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints.
    Winneroski LL; Erickson JA; Green SJ; Lopez JE; Stout SL; Porter WJ; Timm DE; Audia JE; Barberis M; Beck JP; Boggs LN; Borders AR; Boyer RD; Brier RA; Hembre EJ; Hendle J; Garcia-Losada P; Minguez JM; Mathes BM; May PC; Monk SA; Rankovic Z; Shi Y; Watson BM; Yang Z; Mergott DJ
    Bioorg Med Chem; 2020 Jan; 28(1):115194. PubMed ID: 31786008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499.
    Dessolin J
    Expert Opin Ther Pat; 2014 Feb; 24(2):239-42. PubMed ID: 24219148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond.
    Zhu Z
    Trends Pharmacol Sci; 2012 May; 33(5):233-40. PubMed ID: 22480948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp.
    Sun Y; Takada K; Nogi Y; Okada S; Matsunaga S
    J Nat Prod; 2014 Jul; 77(7):1749-52. PubMed ID: 24960234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual screening and structure-based discovery of indole acylguanidines as potent β-secretase (BACE1) inhibitors.
    Zou Y; Li L; Chen W; Chen T; Ma L; Wang X; Xiong B; Xu Y; Shen J
    Molecules; 2013 May; 18(5):5706-22. PubMed ID: 23681056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for bergenin analogues as β-secretase (BACE1) inhibitors.
    Kashima Y; Miyazawa M
    J Oleo Sci; 2013; 62(6):391-401. PubMed ID: 23728330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.